Skip to content
Search

Latest Stories

Guidance released to treat minor eye ailments in Scottish pharmacies

The Scottish government has released guidance for the treatment of minor eye conditions in community pharmacies.

The latest update provides guidance to both community optometry and community pharmacy teams for the assessment and treatment of minor eye conditions under the NHS Pharmacy First Scotland (NHS PFS) service.


According to the guidance, if an optometrist concludes that a patient requires treatment for a minor eye condition, he or she could refer the patient to a pharmacy rather than their GP practice, to obtain a necessary medication.

In such cases, the optometrist can use the necessary form attached to the guidance to request that a supply is made through NHS PFS.

This ensures patients can access the most appropriate service to meet their individual needs in timely manner.

As before with the Minor Ailment Service (MAS), the optometrist’s clinical assessment would be utilised prior to a supply being made and the responsibility for the choice of product based on examination remains with the referring optometrist, the guidance has said.

“Patients who present in the first instance to a pharmacy and do not, in the pharmacist’s opinion, need to go directly to hospital should be directed to a local optometry practice for an eye examination using the same form,” the guidance has said.

“It is good practice that the referring pharmacy contacts the optometry practice by telephone, whilst the patient is still in the pharmacy to confirm availability of an appointment, thus providing a better patient experience. However, this may not always be possible,” it added.

At all times it is essential that patient has a clear understanding of their journey between optometry and pharmacy to ensure this is efficient and safe, whilst allowing the respective healthcare professionals to manage their workloads, the guidance stated.

“After the first supply, the patient should be reviewed by an optometrist to assess the need for ongoing treatment. At this point, a further supply could be made by the pharmacy (to ensure continuity of treatment) and a request submitted by the optometrist to the GP to add the item to the patient’s repeat prescription. The route of obtaining further supplies should be made clear to the patient at this point,” the guidance has said.

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less